HK1220134A1 - 用於口服遞送的活細胞製劑 - Google Patents

用於口服遞送的活細胞製劑

Info

Publication number
HK1220134A1
HK1220134A1 HK16108256.4A HK16108256A HK1220134A1 HK 1220134 A1 HK1220134 A1 HK 1220134A1 HK 16108256 A HK16108256 A HK 16108256A HK 1220134 A1 HK1220134 A1 HK 1220134A1
Authority
HK
Hong Kong
Prior art keywords
formulations
viable cells
oral delivery
oral
delivery
Prior art date
Application number
HK16108256.4A
Other languages
English (en)
Inventor
亞歷山大．愛德華茲
尼加爾．斯拉特
Original Assignee
Cambridge Entpr Ltd
Recipharmcobra Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Entpr Ltd, Recipharmcobra Holdings Ltd filed Critical Cambridge Entpr Ltd
Publication of HK1220134A1 publication Critical patent/HK1220134A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16108256.4A 2009-01-09 2016-07-14 用於口服遞送的活細胞製劑 HK1220134A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0900350.0A GB0900350D0 (en) 2009-01-09 2009-01-09 Formulations of viable bacteria for oral delivery

Publications (1)

Publication Number Publication Date
HK1220134A1 true HK1220134A1 (zh) 2017-04-28

Family

ID=40379384

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108256.4A HK1220134A1 (zh) 2009-01-09 2016-07-14 用於口服遞送的活細胞製劑

Country Status (13)

Country Link
US (1) US10016467B2 (zh)
EP (1) EP2384190B1 (zh)
JP (1) JP5779762B2 (zh)
CN (2) CN102341100A (zh)
AU (1) AU2010204159B2 (zh)
DK (1) DK2384190T3 (zh)
ES (1) ES2640979T3 (zh)
GB (1) GB0900350D0 (zh)
HK (1) HK1220134A1 (zh)
HU (1) HUE034713T2 (zh)
PL (1) PL2384190T3 (zh)
PT (1) PT2384190T (zh)
WO (1) WO2010079343A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6724379B2 (ja) * 2016-01-20 2020-07-15 住友ゴム工業株式会社 空気入りタイヤ
US10220003B2 (en) * 2016-03-09 2019-03-05 Incube Labs, Llc Methods and articles for delivering viable cells into solid tissue
EP3746091A4 (en) * 2018-01-30 2021-10-06 Pharmascience Inc. CHOLESTYRAMINE FORMULATIONS AND METHODS OF USE
JP7348299B2 (ja) 2018-10-30 2023-09-20 バイタボーラス インク． 治療用哺乳動物細胞の経口送達
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
EP4124342A1 (en) 2021-07-28 2023-02-01 Prokarium Limited Cancer therapy with live attenuated bacteria
WO2023105076A1 (en) 2021-12-09 2023-06-15 Prokarium Limited Combination cancer therapy

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2811492A (en) * 1953-06-04 1957-10-29 R J Strasenburgh Company Polyamine sulfonic acid type adsorption compound
US3072528A (en) 1957-07-13 1963-01-08 Med Fabrik Chemisch Pharmazeut Ingestible dry microorganism preparations
BE580490A (fr) 1958-07-15 1960-01-08 Merck & Co Inc Compositions et procédés pour abaisser la teneur en cholestérol du sang
US3383281A (en) * 1961-09-22 1968-05-14 Merck & Co Inc Method for binding bile acids in vivo
US3308020A (en) 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
US3499960A (en) 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin
NL7017227A (zh) 1969-12-27 1971-06-29
WO1983002392A1 (en) 1982-01-18 1983-07-21 Kihara, Kunio Cholesterol lowering drug
KR930001382B1 (ko) * 1990-09-05 1993-02-27 보령신약 주식회사 경구용 장티프스 생균백신 및 그의 제조방법
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
CZ126996A3 (en) 1996-05-02 1997-11-12 Josef Palicka Tablet of vegetables with nutrient and supporting effects on human organism
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
CA2326874C (en) * 1998-04-01 2010-05-25 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
US6610531B1 (en) 1998-09-24 2003-08-26 The United States Of America As Represented By The Secretary Of The Navy Viable dried bacteria produced by drying in the presence of trehalose and divalent cation
SE9901387D0 (sv) * 1999-04-19 1999-04-19 Astra Ab New pharmaceutical foromaulations
GB9914412D0 (en) * 1999-06-22 1999-08-18 Worrall Eric E Method for the preservation of viruses,bacteria and biomolecules
JP3363438B2 (ja) * 2000-05-02 2003-01-08 ビオフェルミン製薬株式会社 噴霧乾燥による菌体乾燥物
SI1307264T1 (en) * 2000-07-28 2005-02-28 F. Hoffmann-La Roche Ag New pharmaceutical composition
EP1421945A4 (en) 2001-08-10 2005-06-22 Hokkaido Tech Licensing Office ABSORBENT / ADSORBENT OF BILARY ACID
JP3621958B2 (ja) 2002-02-08 2005-02-23 株式会社アンデルセン・パン生活文化研究所 胆汁酸を結合する、加熱殺菌処理された乳酸菌菌体およびその乳酸菌菌体を含有する食品素材・食品
JP2004250338A (ja) 2003-02-18 2004-09-09 Sunstar Inc 有用生菌製剤
CA2517245C (en) 2003-02-28 2009-01-20 Mcgill University Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
GB0321228D0 (en) 2003-09-10 2003-10-08 Inpharmatica Ltd Modulating cell activity
US8097245B2 (en) * 2005-12-28 2012-01-17 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
WO2007112747A1 (en) * 2006-03-31 2007-10-11 Curalogic A/S Immunogen combinations
CA2654457A1 (en) * 2006-06-06 2007-12-13 Mcgill University Fermented milk product and use thereof
US20080124355A1 (en) * 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
TWI490003B (zh) * 2007-03-19 2015-07-01 Morishita Jintan Co 經口疫苗
WO2011026111A1 (en) * 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity

Also Published As

Publication number Publication date
EP2384190B1 (en) 2017-07-26
HUE034713T2 (en) 2018-02-28
US20120027811A1 (en) 2012-02-02
AU2010204159A1 (en) 2011-09-01
WO2010079343A2 (en) 2010-07-15
PL2384190T3 (pl) 2018-01-31
PT2384190T (pt) 2017-10-03
JP2012514629A (ja) 2012-06-28
AU2010204159B2 (en) 2015-09-03
EP2384190A2 (en) 2011-11-09
CN102341100A (zh) 2012-02-01
ES2640979T3 (es) 2017-11-07
JP5779762B2 (ja) 2015-09-16
CN105663171A (zh) 2016-06-15
US10016467B2 (en) 2018-07-10
CN105663171B (zh) 2020-09-22
DK2384190T3 (en) 2017-10-16
GB0900350D0 (en) 2009-02-11
WO2010079343A3 (en) 2010-09-02

Similar Documents

Publication Publication Date Title
HK1220134A1 (zh) 用於口服遞送的活細胞製劑
IL218928A (en) Corticosteroids for oral administration
ZA201204672B (en) Oral care compositions
IL269369A (en) The vehicles are improved
RS55151B1 (sr) Farmaceutska kompozicija za oralno davanje
ZA201104894B (en) Solid oral formulations of a pyridopyrimidinone
ZA201107122B (en) Stable pharmaceutical compositions of diclofenac
HK1211207A1 (zh) 改良的藥用氣溶膠製劑
HK1219047A1 (zh) 調節的肺部給藥製劑
EP2694098A4 (en) ORAL ENZYME COMPOSITIONS FOR INTESTINAL ADMINISTRATION
EP2407162A4 (en) COMPOSITION FOR ORAL ADMINISTRATION
EP2501411A4 (en) PROCESS FOR IMPROVED ORAL ADMINISTRATION
EP2474294A4 (en) PREPARATION FOR ORAL ADMINISTRATION
EP2520300A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
IL219860A0 (en) Oral formulation for dexlansoprazole
EP2473168A4 (en) PHARMACEUTICAL FORMULATIONS FOR INDIBULIN
ZA200901424B (en) Stable solid elsamitrucin salts suitable for pharmaceutical formulations
AU2009905978A0 (en) Inhalable formulations
GB0906003D0 (en) Oral drug formulation
GB0914489D0 (en) Improved formulations